Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Material Contracts, 2024

GILEAD SCIENCES, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2024-11-12: Form 10-Q; Exhibit 10.51; Description TRANSITION AND GENERAL RELEASE AGREEMENT (PARSEY).
  • 2024-11-12: Form 10-Q; Exhibit 10.41; Description SEVERANCE PLAN (AMENDED AND RESTATED).
  • 2024-08-08: Form 10-Q; Exhibit 10.37; Description 2024 NON-EMPLOYEE DIRECTOR RSU AGREEMENT.
  • 2024-08-08: Form 10-Q; Exhibit 10.18; Description 2024 NON-EMPLOYEE DIRECTOR STOCK OPTION AGREEMENT.
FiledFormExhibitDescription
2024-11-1210-Q10.51TRANSITION AND GENERAL RELEASE AGREEMENT (PARSEY)
2024-11-1210-Q10.41SEVERANCE PLAN (AMENDED AND RESTATED)
2024-08-0810-Q10.372024 NON-EMPLOYEE DIRECTOR RSU AGREEMENT
2024-08-0810-Q10.182024 NON-EMPLOYEE DIRECTOR STOCK OPTION AGREEMENT
2024-05-0810-Q10.352024 RSU AGREEMENT
2024-05-0810-Q10.272024 PSU AGREEMENT - REVENUE GOALS
2024-05-0810-Q10.222024 PSU AGREEMENT - TSR GOALS
2024-05-0810-Q10.122024 EMPLOYEE STOCK OPTION AGREEMENT

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31